Howie’s 17+ Years After VesCell(TM): Following Hemostemix’s Heart Patients
Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Clinical Trial
Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker...
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and...
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
Strategic partnership with Pioneer Veterinary Products Limited expands Zomedica's presence in the UK veterinary market through distribution of its leading...
Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule
GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA...
CDT Board Authorizes Adoption of Cryptocurrency Treasury Reserve Strategy
Cryptocurrency treasury reserve strategy is designed to diversify capital structure while reinforcing CDT's innovation-led modelNAPLES, Fla. and CAMBRIDGE, United Kingdom,...
Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Media ReleaseCOPENHAGEN, Denmark; September 3, 2025 Trial demonstrated the feasibility of treating and monitoring adult patients with relapsed/refractory (R/R) diffuse...
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage...
Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program
September 16 event to highlight preclinical data on the combination of FTI agents with multiple classes of targeted therapies October...
CG Oncology Completes Enrollment in PIVOT-006
– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized...
Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in...
Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results
All financial results are reported in Canadian dollars unless otherwise stated.Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus...
St. Baldrick’s Foundation Kicks Off Childhood Cancer Awareness Month with New ‘Send Kids’ Cancer Packing’ Initiative
Los Angeles, California--(Newsfile Corp. - September 2, 2025) - Each year, more than 15,000 families in the U.S. hear the...
Quotient Sciences and CPI to Accelerate RNA Drug Development with Joint Venture
NOTTINGHAM, England, Sept. 2, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation...
Medical Horizons and Bowhead Health Inc. Announce Exclusive Partnership to Bring AI-Powered Clinical Research Solutions to Italy, Turkey, and Cyprus
FLORENCE, Italy, Sept. 2, 2025 /PRNewswire/ -- Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI) solutions for...
Adhere+ Expands Remote Therapeutic Monitoring Capabilities with 10 New Protocols Tailored to Clinical Demand
Latest additions address chronic pain, geriatrics, rheumatology, and neuromodulation, supporting more personalized and proactive outpatient care WASHINGTON, Sept. 2, 2025...
EDETEK Launches BioStat.AI: The Industry’s First Unified AI Platform for Clinical Data, Biostatistics, and Programming
Precision, Speed, and Insight—Redefined by BioStat.AI PRINCETON, N.J., Sept. 2, 2025 /PRNewswire/ -- EDETEK Inc., a global leader in digital...
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
LA JOLLA, Calif., Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company...
Florence Announces AI-Assisted Workflows to Transform Clinical Trials
ATLANTA, GA / ACCESS Newswire / September 2, 2025 / Ahead of its premier life science event advancing Clinical Trial...